-
Je něco špatně v tomto záznamu ?
Sex-Related Differences in Platelet Aggregation: A Literature Review Supplemented with Local Data from a Group of Generally Healthy Individuals
A. Carazo, M. Hrubša, L. Konečný, P. Skořepa, M. Paclíková, F. Musil, J. Karlíčková, L. Javorská, K. Matoušová, LK. Krčmová, MS. Parvin, A. Šmahelová, V. Blaha, P. Mladěnka
Jazyk angličtina Země Spojené státy americké
Typ dokumentu přehledy, časopisecké články
PubMed
36206768
DOI
10.1055/s-0042-1756703
Knihovny.cz E-zdroje
- MeSH
- adenosindifosfát farmakologie MeSH
- agregace trombocytů * MeSH
- Aspirin terapeutické užití MeSH
- inhibitory agregace trombocytů * terapeutické užití MeSH
- kyselina 15-hydroxy-11 alfa,9 alfa-(epoxymethano)prosta-5,13-dienová farmakologie MeSH
- kyselina arachidonová farmakologie MeSH
- laktony farmakologie MeSH
- lidé MeSH
- trombocyty MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The process of platelet aggregation is often influenced by several factors including sex and age. A literature review confirmed the existence of sex-related differences in platelet aggregation. Although 68 out of 78 papers found such differences, there are still some controversies regarding these differences, which can be due to multiple factors (age, trigger, concomitant disease, sample handling, etc.). These outcomes are discussed in line with novel results obtained from a local study, in which blood samples from a total of 53 overall healthy women and men with ages ranging from 20 to 66 years were collected. Aggregation was induced with seven different triggers (ristocetin, thrombin receptor activating peptide 6 [TRAP-6], arachidonic acid [AA], platelet-activating factor 16 [PAF-16], ADP, collagen, or thromboxane A2 analog U-46619) ex vivo. In addition, three FDA-approved antiplatelet drugs (vorapaxar, ticagrelor, or acetylsalicylic acid [ASA]) were also tested. In general, women had higher aggregation responses to some agonists (ADP, TRAP), as well as lower benefit from inhibitors (ASA, vorapaxar). The aggregatory responses to AA and TRAP decreased with age in both sexes, while responses to ADP, U-46619, and PAF were affected by age only in women. In conclusion, more studies are needed to decipher the biological importance of sex-related differences in platelet aggregation in part to enable personalized antiplatelet treatment.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23010966
- 003
- CZ-PrNML
- 005
- 20230801132734.0
- 007
- ta
- 008
- 230718s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1055/s-0042-1756703 $2 doi
- 035 __
- $a (PubMed)36206768
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Carazo, Alejandro $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 245 10
- $a Sex-Related Differences in Platelet Aggregation: A Literature Review Supplemented with Local Data from a Group of Generally Healthy Individuals / $c A. Carazo, M. Hrubša, L. Konečný, P. Skořepa, M. Paclíková, F. Musil, J. Karlíčková, L. Javorská, K. Matoušová, LK. Krčmová, MS. Parvin, A. Šmahelová, V. Blaha, P. Mladěnka
- 520 9_
- $a The process of platelet aggregation is often influenced by several factors including sex and age. A literature review confirmed the existence of sex-related differences in platelet aggregation. Although 68 out of 78 papers found such differences, there are still some controversies regarding these differences, which can be due to multiple factors (age, trigger, concomitant disease, sample handling, etc.). These outcomes are discussed in line with novel results obtained from a local study, in which blood samples from a total of 53 overall healthy women and men with ages ranging from 20 to 66 years were collected. Aggregation was induced with seven different triggers (ristocetin, thrombin receptor activating peptide 6 [TRAP-6], arachidonic acid [AA], platelet-activating factor 16 [PAF-16], ADP, collagen, or thromboxane A2 analog U-46619) ex vivo. In addition, three FDA-approved antiplatelet drugs (vorapaxar, ticagrelor, or acetylsalicylic acid [ASA]) were also tested. In general, women had higher aggregation responses to some agonists (ADP, TRAP), as well as lower benefit from inhibitors (ASA, vorapaxar). The aggregatory responses to AA and TRAP decreased with age in both sexes, while responses to ADP, U-46619, and PAF were affected by age only in women. In conclusion, more studies are needed to decipher the biological importance of sex-related differences in platelet aggregation in part to enable personalized antiplatelet treatment.
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a agregace trombocytů $7 D010974
- 650 _2
- $a kyselina 15-hydroxy-11 alfa,9 alfa-(epoxymethano)prosta-5,13-dienová $x farmakologie $7 D019796
- 650 12
- $a inhibitory agregace trombocytů $x terapeutické užití $7 D010975
- 650 _2
- $a laktony $x farmakologie $7 D007783
- 650 _2
- $a Aspirin $x terapeutické užití $7 D001241
- 650 _2
- $a kyselina arachidonová $x farmakologie $7 D016718
- 650 _2
- $a adenosindifosfát $x farmakologie $7 D000244
- 650 _2
- $a trombocyty $7 D001792
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hrubša, Marcel $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Konečný, Lukáš $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Skořepa, Pavel $u 3rd Department of Internal Medicine-Metabolic Care and Gerontology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic $u Department of Military Internal Medicine and Military Hygiene, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic
- 700 1_
- $a Paclíková, Markéta $u 3rd Department of Internal Medicine-Metabolic Care and Gerontology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Musil, František $u Department of Occupational Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Karlíčková, Jana $u Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Javorská, Lenka $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Matoušová, Kateřina $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic
- 700 1_
- $a Krčmová, Lenka Kujovská $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Parvin, Mst Shamima $u Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Šmahelová, Alena $u 3rd Department of Internal Medicine-Metabolic Care and Gerontology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Blaha, Vladimír $u 3rd Department of Internal Medicine-Metabolic Care and Gerontology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 700 1_
- $a Mladěnka, Přemysl $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic
- 773 0_
- $w MED00010623 $t Seminars in thrombosis and hemostasis $x 1098-9064 $g Roč. 49, č. 5 (2023), s. 488-506
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36206768 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132731 $b ABA008
- 999 __
- $a ok $b bmc $g 1963411 $s 1197231
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 49 $c 5 $d 488-506 $e 20221007 $i 1098-9064 $m Seminars in thrombosis and hemostasis $n Semin Thromb Hemost $x MED00010623
- LZP __
- $a Pubmed-20230718